Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://www.primetherapeutics.com/w/beyond-the-needle-what-you-need-to-know-about-oral-glp-1s Example Link

GLP-1

Beyond the needle: What you need to know about oral GLP-1s

December 11, 2025

https://www.primetherapeutics.com/w/fda-decisions-expected-january-2026 /fda-decisions-expected-january-2026

Research & Publications

FDA Decisions Expected: January 2026

December 16, 2025

https://www.primetherapeutics.com/w/prime-careers-spotlight-december-2025 /prime-careers-spotlight-december-2025

Stories

Prime Careers Spotlight: December 2025

December 15, 2025

https://www.primetherapeutics.com/w/beyond-the-needle-what-you-need-to-know-about-oral-glp-1s

Stories

Beyond the needle: What you need to know about oral GLP-1s

December 11, 2025

The Latest

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-therapeutics-to-present-latest-managed-care-pharmacy-insights-at-amcp-nexus-2025

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

October 27, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

June 25, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-highlights-industry-leading-glp-1-research-at-amcp-2025

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

March 31, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-glp-1-research-year-2-cost-of-care-is-4-200-higher-for-patients-with-obesity

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

October 24, 2024

https://www.primetherapeutics.com/w/prime-therapeutics-bolsters-its-position-as-industry-leader-with-10-research-studies-at-amcp-nexus-2024

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

October 10, 2024

https://www.primetherapeutics.com/w/prime-continues-to-lead-industry-on-glp-1-research-1-in-7-stays-on-glp-1-drugs-for-weight-loss-after-two-years

Prime continues to lead industry on GLP-1 research: 1 in 7 stays on GLP-1 drugs for weight loss after two years

July 10, 2024

Showing 1 to 6 of 10

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/inflammatory-bowel-disease-at-the-crossroads-of-medical-and-pharmacy

Inflammatory bowel disease at the crossroads of medical and pharmacy

November 25, 2025

https://www.primetherapeutics.com/w/end-of-year-outlook-what-s-next-for-drug-approvals-pipeline-and-innovation

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

November 10, 2025

https://www.primetherapeutics.com/w/integrated-oncology-insights-navigating-the-medical-and-pharmacy-claims-landscape

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

October 23, 2025

https://www.primetherapeutics.com/w/how-to-safely-dispose-of-medications-on-national-drug-take-back-day

How to safely dispose of medications on National Drug Take Back Day

October 20, 2025

https://www.primetherapeutics.com/w/15-years-of-insight-prime-s-medical-pharmacy-trend-report-a-must-read-for-payers

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

October 02, 2025

https://www.primetherapeutics.com/w/abby-kim-leads-the-charge-in-advancing-lung-cancer-care

Abby Kim leads the charge in advancing lung cancer care

October 01, 2025

Showing 1 to 6 of 68

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-careers-spotlight-december-2025 /prime-careers-spotlight-december-2025

Prime Careers Spotlight: December 2025

December 15, 2025

https://www.primetherapeutics.com/w/beyond-the-needle-what-you-need-to-know-about-oral-glp-1s

Beyond the needle: What you need to know about oral GLP-1s

December 11, 2025

https://www.primetherapeutics.com/w/oncology-trends-the-latest-innovations-in-cancer-care

Oncology Trends: The latest innovations in cancer care

November 21, 2025

https://www.primetherapeutics.com/w/amcp-nexus-2025-the-specialty-surge-how-to-stay-atop-the-latest-in-trend-and-spend

AMCP Nexus 2025: The specialty surge — How to stay atop the latest in trend and spend

November 17, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-recognized-for-building-a-culture-of-continuous-learning

Prime Therapeutics recognized for building a culture of continuous learning

November 17, 2025

https://www.primetherapeutics.com/w/prime-careers-spotlight-november-2025 /prime-careers-spotlight-november-2025

Prime Careers Spotlight: November 2025

November 14, 2025

Showing 1 to 6 of 162

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-presents-at-73rd-annual-roy-a-bowers-pharmaceutical-conference-on-nov-11

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

October 29, 2025

https://www.primetherapeutics.com/w/prime-presents-at-hlth-usa-conference-on-oct-20

Prime presents at HLTH USA conference on Oct. 20

October 17, 2025

https://www.primetherapeutics.com/w/prime-presents-2025-medical-pharmacy-trend-report-webcast-on-oct-13

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

September 23, 2025

https://www.primetherapeutics.com/w/prime-expert-presents-at-the-most-favored-nation-mandate-webinar

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

September 02, 2025

https://www.primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

https://www.primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

Showing 1 to 6 of 37

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/help-net-security-healthcare-security-is-broken-because-its-systems-can-t-talk-to-each-other https://www.helpnetsecurity.com/2025/11/13/cameron-kracke-prime-therapecutics-healthcare-security-ecosystem/

Help Net Security: Healthcare security is broken because its systems can’t talk to each other

November 13, 2025

https://www.primetherapeutics.com/w/ajmc-bridging-the-gap-between-cutting-edge-cancer-care-and-equitable-access https://www.ajmc.com/view/bridging-the-gap-between-cutting-edge-cancer-care-and-equitable-access

AJMC: Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access

November 10, 2025

https://www.primetherapeutics.com/w/drug-store-news-emblemhealth-taps-amazon-pharmacy-for-new-pharmacy-benefit https://drugstorenews.com/emblemhealth-taps-amazon-pharmacy-new-pharmacy-benefit

Drug Store News: EmblemHealth taps Amazon Pharmacy for new pharmacy benefit

November 03, 2025

https://www.primetherapeutics.com/w/managed-healthcare-executive-automated-prior-authorization-speeds-approval-of-glp-1-therapies-amcp-nexus-2025 https://www.managedhealthcareexecutive.com/view/automated-prior-authorization-speeds-approval-of-glp-1-therapies-amcp-nexus-2025

Managed Healthcare Executive: Automated Prior Authorization Speeds Approval of GLP-1 Therapies | AMCP Nexus 2025

October 31, 2025

https://www.primetherapeutics.com/w/managed-healthcare-executive-payers-are-bracing-for-the-specialty-trend-of-the-future-amcp-nexus-2025 https://www.managedhealthcareexecutive.com/view/payers-are-bracing-for-the-specialty-trend-of-the-future-amcp-nexus-2025

Managed Healthcare Executive: Payers Are Bracing for the Specialty Trend of the Future | AMCP Nexus 2025

October 30, 2025

https://www.primetherapeutics.com/w/fierce-healthcare-prime-therapeutics-takes-sempre-health-s-pricing-model-nationwide https://www.fiercehealthcare.com/payers/prime-therapeutics-takes-sempre-healths-pricing-model-nationwide

Fierce Healthcare: Prime Therapeutics takes Sempre Health's pricing model nationwide

October 30, 2025

Showing 1 to 6 of 127

Categories

PA Research & Publications

https://www.primetherapeutics.com/w/fda-decisions-expected-january-2026 /fda-decisions-expected-january-2026

FDA Decisions Expected: January 2026

December 16, 2025

https://www.primetherapeutics.com/w/oncology-insights-december-2025 /oncology-insights-december-2025

Oncology Insights: December 2025

December 11, 2025

https://www.primetherapeutics.com/w/expert-clinical-network-insights-december-2025 /expert-clinical-network-insights-december-2025

Expert Clinical Network Insights: December 2025

December 10, 2025

https://www.primetherapeutics.com/w/trending-topics-drug-approvals-december-2025 /trending-topics-drug-approvals-december-2025

GLP-1 Pipeline Update: November 2025

November 20, 2025

https://www.primetherapeutics.com/w/fda-decisions-expected-december-2025 /fda-decisions-expected-december-2025

FDA Decisions Expected: December 2025

November 18, 2025

Showing 1 to 6 of 190

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

Beyond the needle: What you need to know about oral GLP-1s

FDA Decisions Expected: January 2026

Prime Careers Spotlight: December 2025

Beyond the needle: What you need to know about oral GLP-1s

The Latest

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Prime continues to lead industry on GLP-1 research: 1 in 7 stays on GLP-1 drugs for weight loss after two years

Inflammatory bowel disease at the crossroads of medical and pharmacy

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

How to safely dispose of medications on National Drug Take Back Day

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

Abby Kim leads the charge in advancing lung cancer care

Prime Careers Spotlight: December 2025

Beyond the needle: What you need to know about oral GLP-1s

Oncology Trends: The latest innovations in cancer care

AMCP Nexus 2025: The specialty surge — How to stay atop the latest in trend and spend

Prime Therapeutics recognized for building a culture of continuous learning

Prime Careers Spotlight: November 2025

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

Prime presents at HLTH USA conference on Oct. 20

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

Prime presents at ISG Digital Business Summit on Nov. 14

Help Net Security: Healthcare security is broken because its systems can’t talk to each other

AJMC: Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access

Drug Store News: EmblemHealth taps Amazon Pharmacy for new pharmacy benefit

Managed Healthcare Executive: Automated Prior Authorization Speeds Approval of GLP-1 Therapies | AMCP Nexus 2025

Managed Healthcare Executive: Payers Are Bracing for the Specialty Trend of the Future | AMCP Nexus 2025

Fierce Healthcare: Prime Therapeutics takes Sempre Health's pricing model nationwide

FDA Decisions Expected: January 2026

Oncology Insights: December 2025

Expert Clinical Network Insights: December 2025

Trending Topics & Drug Approvals: December 2025

GLP-1 Pipeline Update: November 2025

FDA Decisions Expected: December 2025

Login Portals

Compliance / Legal

Company